Key result
CMR-assessed ischemia in HCM is linked to disease severity, fibrosis, arrhythmias, and functional capacity.
Why the study?
Does ischemia assessed by magnetic resonance associate with morphological markers of severity of disease, fibrosis, arrhythmia, and functional capacity in patients with hypertrophic cardiomyopathy?
Does ischemia assessed by magnetic resonance associate with morphological markers of severity of disease, fibrosis, arrhythmia, and functional capacity in patients with hypertrophic cardiomyopathy?
Ischemia assessed by magnetic resonance is associated with disease severity, fibrosis, arrhythmias, and functional capacity in patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Should not change hypertrophic cardiomyopathy management; leaves open whether ischemia modification improves outcomes.
In HCM, ischemia associates with morphological markers of severity of disease, fibrosis, arrhythmia, and functional capacity.
No takes yet. Share an insight, caveat, or question.
Rosa et al. (2021) studied this question. Magnetic resonance-assessed ischemia in hypertrophic cardiomyopathy is associated with morphological markers of disease severity, fibrosis, arrhythmia, and functional capacity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: